to this date, a promising cell-culture system has yet to be developed in a way that could support large scale need of future vaccine trials. the use of hcv non-structural proteins to initiate immune response in animal studies have shown promising results but the lack of robust tissue culture system and the ability of virus to mutate rapidly are still major hurdles. interferon treatment has succeeded in only very small number of patients.